Arpad Fabian-kovacs

Array ( [id] => 5315568 [patent_doc_number] => 20090280166 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-11-12 [patent_title] => 'FERRITIN AS A THERAPEUTIC TARGET IN ABNORMAL CELLS' [patent_app_type] => utility [patent_app_number] => 12/422709 [patent_app_country] => US [patent_app_date] => 2009-04-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 28908 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0280/20090280166.pdf [firstpage_image] =>[orig_patent_app_number] => 12422709 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5495421 [patent_doc_number] => 20090263449 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-22 [patent_title] => 'DELIVERY OF NUCLEIC ACID COMPLEXES FROM MATERIALS INCLUDING NEGATIVELY CHARGED GROUPS' [patent_app_type] => utility [patent_app_number] => 12/421285 [patent_app_country] => US [patent_app_date] => 2009-04-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 11246 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0263/20090263449.pdf [firstpage_image] =>[orig_patent_app_number] => 12421285 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5385178 [patent_doc_number] => 20090226423 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-09-10 [patent_title] => 'Protein kinase C as a target for the treatment of respiratory syncytial virus' [patent_app_type] => utility [patent_app_number] => 12/384384 [patent_app_country] => US [patent_app_date] => 2009-04-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 15189 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0226/20090226423.pdf [firstpage_image] =>[orig_patent_app_number] => 12384384 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8876033 [patent_doc_number] => 08470999 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-06-25 [patent_title] => 'Oligonucleotides for treating inflammation and neoplastic cell proliferation' [patent_app_type] => utility [patent_app_number] => 12/992885 [patent_app_country] => US [patent_app_date] => 2009-03-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 29693 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12992885 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7574158 [patent_doc_number] => 20110269814 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-11-03 [patent_title] => '2\'-F MODIFIED RNA INTERFERENCE AGENTS' [patent_app_type] => utility [patent_app_number] => 12/935083 [patent_app_country] => US [patent_app_date] => 2009-03-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 87518 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0269/20110269814.pdf [firstpage_image] =>[orig_patent_app_number] => 12935083 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8772422 [patent_doc_number] => 08426378 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-04-23 [patent_title] => 'Oligomeric compounds comprising tricyclic nucelosides and methods for their use' [patent_app_type] => utility [patent_app_number] => 12/922832 [patent_app_country] => US [patent_app_date] => 2009-03-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 28535 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 63 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12922832 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6196773 [patent_doc_number] => 20110028531 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-02-03 [patent_title] => 'NOVEL SIRNA COMPOUNDS FOR INHIBITING RTP801' [patent_app_type] => utility [patent_app_number] => 12/736230 [patent_app_country] => US [patent_app_date] => 2009-03-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 45757 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0028/20110028531.pdf [firstpage_image] =>[orig_patent_app_number] => 12736230 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6630079 [patent_doc_number] => 20100004315 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-01-07 [patent_title] => 'Biodegradable Cross-Linked Branched Poly(Alkylene Imines)' [patent_app_type] => utility [patent_app_number] => 12/404989 [patent_app_country] => US [patent_app_date] => 2009-03-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 12035 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0004/20100004315.pdf [firstpage_image] =>[orig_patent_app_number] => 12404989 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6026489 [patent_doc_number] => 20110054009 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-03 [patent_title] => 'MicroRNA-Based Methods and Compositions for the Diagnosis, Prognosis and Treatment of Prostate Related Disorders' [patent_app_type] => utility [patent_app_number] => 12/919888 [patent_app_country] => US [patent_app_date] => 2009-02-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 26 [patent_no_of_words] => 36536 [patent_no_of_claims] => 76 [patent_no_of_ind_claims] => 42 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0054/20110054009.pdf [firstpage_image] =>[orig_patent_app_number] => 12919888 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6024176 [patent_doc_number] => 20110052502 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-03 [patent_title] => 'MicroRNA Signatures Associated with Human Chronic Lymphocytic Leukemia (CCL) and Uses Thereof' [patent_app_type] => utility [patent_app_number] => 12/919904 [patent_app_country] => US [patent_app_date] => 2009-02-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 187 [patent_figures_cnt] => 187 [patent_no_of_words] => 24254 [patent_no_of_claims] => 50 [patent_no_of_ind_claims] => 37 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0052/20110052502.pdf [firstpage_image] =>[orig_patent_app_number] => 12919904 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6001692 [patent_doc_number] => 20110117567 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-19 [patent_title] => 'Micro-RNA Associated With Rheumatoid Arthritis' [patent_app_type] => utility [patent_app_number] => 13/001812 [patent_app_country] => US [patent_app_date] => 2009-02-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 6102 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0117/20110117567.pdf [firstpage_image] =>[orig_patent_app_number] => 13001812 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6538586 [patent_doc_number] => 20100204299 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-12 [patent_title] => 'C-CBL AND ANTAGONISTS THEREOF FOR THE TREATMENT AND DIAGNOSIS OF CANCER' [patent_app_type] => utility [patent_app_number] => 12/369309 [patent_app_country] => US [patent_app_date] => 2009-02-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 11930 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0204/20100204299.pdf [firstpage_image] =>[orig_patent_app_number] => 12369309 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5503013 [patent_doc_number] => 20090163701 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-06-25 [patent_title] => 'siRNA targeting tumor necrosis factor receptor superfamily member 1A' [patent_app_type] => utility [patent_app_number] => 12/322980 [patent_app_country] => US [patent_app_date] => 2009-02-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 45 [patent_figures_cnt] => 45 [patent_no_of_words] => 28671 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0163/20090163701.pdf [firstpage_image] =>[orig_patent_app_number] => 12322980 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6047606 [patent_doc_number] => 20110207197 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-08-25 [patent_title] => 'METHOD TO INHIBIT RIBONUCLEASE DICER, RIBONUCLEASE DICER INHIBITOR, AND USE OF RNA APTAMERS AS RIBONUCLEASE DICER INHIBITORS' [patent_app_type] => utility [patent_app_number] => 12/867471 [patent_app_country] => US [patent_app_date] => 2009-02-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 7675 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0207/20110207197.pdf [firstpage_image] =>[orig_patent_app_number] => 12867471 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6003442 [patent_doc_number] => 20110118340 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-19 [patent_title] => 'DELIVERY OF RNAI CONSTRUCTS TO OLIGODENDROCYTES' [patent_app_type] => utility [patent_app_number] => 12/866444 [patent_app_country] => US [patent_app_date] => 2009-02-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 39628 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0118/20110118340.pdf [firstpage_image] =>[orig_patent_app_number] => 12866444 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 16650206 [patent_doc_number] => 10927371 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-02-23 [patent_title] => Cationic siRNAs, synthesis and use for RNA interference [patent_app_type] => utility [patent_app_number] => 12/735595 [patent_app_country] => US [patent_app_date] => 2009-01-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 6 [patent_no_of_words] => 4511 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 86 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12735595 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6580459 [patent_doc_number] => 20100291036 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-18 [patent_title] => 'COMPOSITIONS AND METHODS FOR MODULATING VASCULAR ENDOTHELIAL GROWTH FACTOR C (VEGF-C) EXPRESSION' [patent_app_type] => utility [patent_app_number] => 12/812735 [patent_app_country] => US [patent_app_date] => 2009-01-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 15993 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0291/20100291036.pdf [firstpage_image] =>[orig_patent_app_number] => 12812735 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6254964 [patent_doc_number] => 20100029003 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-02-04 [patent_title] => 'System and methods for identifying miRNA targets and for altering miRNA and target expression' [patent_app_type] => utility [patent_app_number] => 12/321489 [patent_app_country] => US [patent_app_date] => 2009-01-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 55 [patent_figures_cnt] => 55 [patent_no_of_words] => 58593 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12321489 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5354695 [patent_doc_number] => 20090186039 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-23 [patent_title] => 'NOVEL USE OF GRP 94 IN VIRUS INFECTION' [patent_app_type] => utility [patent_app_number] => 12/355747 [patent_app_country] => US [patent_app_date] => 2009-01-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 9367 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0186/20090186039.pdf [firstpage_image] =>[orig_patent_app_number] => 12355747 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5354715 [patent_doc_number] => 20090186059 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-23 [patent_title] => 'DEVICES AND METHODS FOR ELUTION OF NUCLEIC ACID DELIVERY COMPLEXES' [patent_app_type] => utility [patent_app_number] => 12/353792 [patent_app_country] => US [patent_app_date] => 2009-01-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 11352 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0186/20090186059.pdf [firstpage_image] =>[orig_patent_app_number] => 12353792 [rel_patent_id] =>[rel_patent_doc_number] =>)